ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase

May 27, 1994